Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BATS BZX Real-Time Price
As of 1:53pm ET
 +0.07 / +0.18%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Alere, Inc. develops, manufactures and markets consumer and professional medical diagnostic products. The company's products and services focus on cardiology, infectious disease, women's health, oncology, and toxicology. Its portfolio also includes a broad array of health information solutions that increase access to critical health data, provide clinical decision support, and facilitate more comprehensive performance reporting and analysis. The company operates its business through the following segments: Professional Diagnostics, Health Information Solutions, and Consumer Diagnostics. The Professional Diagnostics segment includes an array of innovative rapid diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The Health Information Solutions segment provides comprehensive, integrated programs and services focused on wellness, disease and condition management, productivity enhancement and informatics, all designed to reduce health-related costs and enhance the health and quality of life of the individuals. The Consumer Diagnostics segment manufactures products for SPD Swiss Precision Diagnostics, the company's joint venture with The Procter & Gamble Co. Its Consumer Diagnostic products consist of First Check brand of over-the-counter drug tests for at-home testing for up to seven illicit drugs and five prescription drugs, as well as First Check brand over-the-counter tests for cholesterol monitoring. Alere was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Waltham, MA.

Contact Information

Alere, Inc.
51 Sawyer Road
Waltham Massachusetts 02453-3448
P:(781) 647-3900
Investor Relations:
(858) 805-2232



Individual stakeholders6.85%
Other institutional48.99%
Mutual fund holders45.66%

Top Executives

Namal NawanaPresident, Chief Executive Officer & Director
Mark GladwellSenior Vice President-Global Operations
James F. HinrichsChief Financial Officer & Executive Vice President
Renuka UppaluriSenior Vice President-Research & Development
Ellen V. ChiniaraSecretary, Chief Ethics & Compliance Officer